BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31557623)

  • 21. Discovery of novel dual-active 3-(4-(dimethylamino)phenyl)-7-aminoalcoxy-coumarin as potent and selective acetylcholinesterase inhibitor and antioxidant.
    de Souza GA; da Silva SJ; Del Cistia CN; Pitasse-Santos P; Pires LO; Passos YM; Cordeiro Y; Cardoso CM; Castro RN; Sant'Anna CMR; Kümmerle AE
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):631-637. PubMed ID: 30727776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors.
    Chen SC; Qiu GL; Li B; Shi JB; Liu XH; Tang WJ
    Eur J Med Chem; 2018 Mar; 147():194-204. PubMed ID: 29438888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
    Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
    J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid discovery of a selective butyrylcholinesterase inhibitor using structure-based virtual screening.
    Miles JA; Kapure JS; Deora GS; Courageux C; Igert A; Dias J; McGeary RP; Brazzolotto X; Ross BP
    Bioorg Med Chem Lett; 2020 Dec; 30(24):127609. PubMed ID: 33039562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
    Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA
    Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening.
    Dighe SN; Deora GS; De la Mora E; Nachon F; Chan S; Parat MO; Brazzolotto X; Ross BP
    J Med Chem; 2016 Aug; 59(16):7683-9. PubMed ID: 27405689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives.
    Alipour M; Khoobi M; Moradi A; Nadri H; Homayouni Moghadam F; Emami S; Hasanpour Z; Foroumadi A; Shafiee A
    Eur J Med Chem; 2014 Jul; 82():536-44. PubMed ID: 24941128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New (benz)imidazolopyridino tacrines as nonhepatotoxic, cholinesterase inhibitors for Alzheimer disease.
    Boulebd H; Ismaili L; Martin H; Bonet A; Chioua M; Marco Contelles J; Belfaitah A
    Future Med Chem; 2017 May; 9(8):723-729. PubMed ID: 28485637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies.
    Cavdar H; Senturk M; Guney M; Durdagi S; Kayik G; Supuran CT; Ekinci D
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):429-437. PubMed ID: 30734597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
    Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
    Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
    Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hybridization-based design of novel anticholinesterase indanone-carbamates for Alzheimer's disease: Synthesis, biological evaluation, and docking studies.
    Shahrivar-Gargari M; Hamzeh-Mivehroud M; Hemmati S; Mojarrad JS; Tüylü Küçükkılınç T; Ayazgök B; Dastmalchi S
    Arch Pharm (Weinheim); 2021 Jul; 354(7):e2000453. PubMed ID: 33872422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
    Kumar RS; Almansour AI; Arumugam N; Althomili DMQ; Altaf M; Basiri A; D K; Sai Manohar T; S V
    Bioorg Chem; 2018 Apr; 77():263-268. PubMed ID: 29421701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of new acetylcholinesterase inhibitors for Alzheimer's disease: virtual screening and
    David B; Schneider P; Schäfer P; Pietruszka J; Gohlke H
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):491-496. PubMed ID: 33478277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and evaluation of novel 5,6,7-trimethoxyflavone-6-chlorotacrine hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Liao S; Deng H; Huang S; Yang J; Wang S; Yin B; Zheng T; Zhang D; Liu J; Gao G; Ma J; Deng Z
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1541-5. PubMed ID: 25724825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
    Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
    Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active compounds from a diverse library of triazolothiadiazole and triazolothiadiazine scaffolds: synthesis, crystal structure determination, cytotoxicity, cholinesterase inhibitory activity, and binding mode analysis.
    Khan I; Ibrar A; Zaib S; Ahmad S; Furtmann N; Hameed S; Simpson J; Bajorath J; Iqbal J
    Bioorg Med Chem; 2014 Nov; 22(21):6163-73. PubMed ID: 25257911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel carbamate derivatives as selective butyrylcholinesterase inhibitors.
    Bajda M; Łątka K; Hebda M; Jończyk J; Malawska B
    Bioorg Chem; 2018 Aug; 78():29-38. PubMed ID: 29529519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.